Caspofungin Intravenous (IV) Powder bulk supplier for pharma manufacturers

Caspofungin Intravenous (Iv) Powder 50 mg/vial, 70 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Powder

Available Strengths: 50 mg/vial, 70 mg/vial

Reference Brands: Cancidas (US & EU)

Caspofungin inhibits fungal β-glucan synthase, disrupting fungal cell wall synthesis and causing cell death. It provides broad-spectrum activity against invasive fungi like Candida and Aspergillus. Benefits include rapid action, effectiveness in severe infections, minimal toxicity, and suitability for immunocompromised patients, making it vital for life-threatening fungal diseases.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Caspofungin IV powder is approved in the EU and US for treating invasive fungal infections. In the EU, Merck’s Cancidas is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We facilitate efficient market access for caspofungin IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Caspofungin Intravenous (Iv) Powder — third party manufacturing & bulk supply

Caspofungin Intravenous (Iv) Powder 50 mg/vial, 70 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Caspofungin Intravenous (Iv) Powder is supplied as Intravenous (IV) Powder — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Caspofungin Intravenous (Iv) Powder listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Caspofungin Intravenous (Iv) Powder →

Back to Listing

Frequently Asked Questions

Caspofungin Intravenous (IV) Powder is listed as Intravenous (IV) Powder in 50 mg/vial, 70 mg/vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Caspofungin Intravenous (IV) Powder is referenced against Cancidas (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.